Background: Receptor tyrosine phosphatases (RPTPs) are essential for axon guidance and synaptogenesis in Drosophila. Each guidance decision made by embryonic motor axons during outgrowth to their muscle targets requires a specific subset of the five neural RPTPs. The logic underlying these requirements, however, is still unclear, partially because the ligands recognized by RPTPs at growth cone choice points have not been identified. RPTPs in general are still "orphan receptors" because, while they have been found to interact in vitro with many different proteins, their in vivo ligands are unknown. Results: Here we use a new type of deficiency screen to identify the transmembrane heparan sulfate proteoglycan Syndecan (Sdc) as a ligand for the neuronal RPTP LAR. LAR interacts with the glycosaminoglycan chains of Syndecan in vitro with nanomolar affinity. Genetic interaction studies using Sdc and Lar LOF mutations demonstrate that Sdc contributes to LAR's function in motor axon guidance. We also show that overexpression of Sdc on muscles generates the same phenotype as overexpression of LAR in neurons and that genetic removal of LAR suppresses the phenotype produced by ectopic muscle Sdc. Finally, we show that there is at least one additional, nonproteoglycan, ligand for LAR encoded in the genome. Conclusions: Taken together, our results demonstrate that Sdc on muscles can interact with neuronal LAR in vivo and that binding to Sdc increases LAR's signaling efficacy. Thus, Sdc is a ligand that can act in trans to positively regulate signal transduction through LAR within neuronal growth cones.
Introduction
Signaling through tyrosine phosphorylation is essential for axon guidance. Two large families of enzymes, protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs), directly control phosphorylation of axonal proteins on tyrosine residues. Many of the PTPs are receptor-like molecules (RPTPs) that have extracellular domains related in sequence to cell-adhesion molecules (CAMs), connected via a single transmembrane domain to either one or two cytoplasmic PTP domains.
The structural similarity of RPTPs to receptor tyrosine kinases (RTKs) has led to the hypothesis that extracellular ligands modulate RPTP activity, as they do with *Correspondence: zinnk@caltech.edu RTKs. To date, however, RPTPs are still "orphan receptors" because, while they have been found to interact with many different proteins, their physiologically relevant ligands are unknown (reviewed by [1] ). The only RPTP-ligand interaction that has been shown to have an effect on signaling is that of RPTP-β/ζ with the secreted growth factor pleiotrophin/HB-GAM; pleiotrophin binding increases phosphorylation of β-catenin in cell culture [2] . RPTP-β/ζ binds to a number of other proteins in vitro as well, including known CAMs (reviewed by [3] ).
Several RPTPs can mediate homophilic adhesion, suggesting that they function as their own ligands (reviewed by [1] ). The mammalian LAR RPTP can bind to a laminin-nidogen complex [4] . Finally, and most relevant to the present study, in vitro binding studies have shown that heparin and heparan sulfate proteoglycans (HSPGs) directly interact with avian RPTPσ, a close relative of LAR. This same RPTP also binds to a non-HSPG protein in muscle [5] . However, it is unknown whether HSPGs or the muscle protein contribute to RPTPσ function in vivo [6] .
Drosophila has provided a unique system for investigation of the in vivo roles of RPTPs during neural development (reviewed by [7] ). The fly genome encodes six RPTPs, five of which are selectively expressed in neurons. Genetic studies of these five neural RPTPs have shown that they are required for axon guidance and synaptogenesis during both embryonic and larval stages.
Embryonic motor axons navigate to their muscle targets along five major nerve pathways (ISN, ISNb, ISNd, SNa, and SNc; see http://www.its.caltech.edu/wzinnlab/ motoraxons/fma%20home%20page.html for diagrams and images of the motor axon/muscle system). Analysis of motor axon guidance phenotypes in Rptp single mutants and mutant combinations has revealed that each growth cone guidance decision made by motor axons requires a specific subset of the five neural RPTPs [8] [9] [10] [11] [12] [13] . Most Rptp single mutant phenotypes are partially penetrant, because several RPTPs can participate in each guidance decision. To generate a highly penetrant alteration in motor axon guidance, it is usually necessary to remove a specific combination of two or more RPTPs.
The combinatorial roles of RPTPs in regulating specific guidance decisions could be explained by a model in which ligands for particular RPTPs are located near each growth cone choice point and that these control the specificity of RPTP function. In this model, a particular RPTP might participate in an axon guidance decision only if its ligand is contacted by the relevant growth cones at the time at which they are making the decision.
The RPTP LAR is involved in guidance of ISNb motor axons at the entrance to their target ventrolateral muscle (VLM) field. In Lar mutants, these axons leave the common ISN pathway at the "exit junction" but then fail to enter the VLM field to innervate their muscle targets. Instead, they continue to grow dorsally in a bundle adjacent to the common ISN pathway.
In this paper, we employ a deficiency screen to identify a cell-surface HSPG, Syndecan (known as Sdc in Drosophila) [14] , as an in vivo ligand for LAR. Syndecans are cell-surface HSPGs that have transmembrane regions. However, they can also be cleaved to produce free extracellular domains that are shed into the medium. Another class of cell-surface HSPGs, the glypicans, is attached to the membrane via glycosyl-phosphatidylinositol (GPI) linkages (reviewed by [15] ).
Syndecans consist of an extracellular core protein domain of w250 amino acids (aa) to which long glycosaminoglycan (HS-GAG) side chains are attached, followed by a transmembrane domain and a short cytoplasmic domain. The GAG chains are composed of repeating disaccharide units that are sulfated at specific positions. They are attached, polymerized, and modified by a complex biosynthetic pathway involving the activities of many different enzymes.
HSPGs are involved in many different cellular processes, among which are adhesion, motility, proliferation, differentiation, and morphogen transport. In Drosophila, the glypicans Dally and Dally-like (Dlp) are required for Hedgehog and Wingless singnaling (reviewed by [15, 16] HSPGs also have roles in axon guidance. They work together with FGF signaling to control axon guidance in the Xenopus visual system and are required for attraction of growth cones to Semaphorin 5A (reviewed by [17, 18] ). HSPGs also regulate axon guidance via the Slit/Robo pathway in Drosophila and zebrafish [19] [20] [21] .
Our findings in this paper provide a new mechanism for HSPG-mediated axon guidance. We identified Sdc in a screen for ligands of the Drosophila LAR RPTP and characterized its interactions with LAR by using biochemistry and genetics. Our results indicate that Sdc expressed on muscles can positively regulate LAR signaling in motor neurons.
Results

A Deficiency Screen for Genes Encoding LAR Ligands
To search for ligands of the Drosophila RPTPs, we first devised an in vivo staining procedure based on the affinity probe techniques developed by Flanagan and colleagues (reviewed by [22] Figure  1B ), intense stripes of staining at muscle attachment sites in the periphery (Figure 1C) , and a segmentally repeated pattern of midline and exit glia in the CNS ( Figure 1A) . The muscle attachment site and glial staining patterns have distinctive dot-like morphologies. We also generated and tested similar AP fusion proteins for the DPTP10D, DPTP99A, and DPTP69D RPTPs, and we found that each produces a distinctive staining pattern on live embryo filets (A. Schmid, A.N.F., and K.Z., unpublished results). Unconjugated PLAP and a variety of other AP fusion proteins exhibited no specific binding to embryos ( Figure S1 , Table S1 ).
To identify the genomic region(s) encoding the putative LAR ligands responsible for this staining pattern, we dissected and stained live embryos homozygous for each of the deletion mutations in the Bloomington Stock Center deficiency kit, which at that time contained about 225 lines. We identified a second chromosome deletion, Df(2R)AA21, which eliminated the bright peripheral LAR-AP staining at muscle attachment sites and also removed most of the dot-like glial staining. CNS axons were still stained in deletion embryos, however.
By performing complementation crosses with overlapping deletions and staining embryos from these crosses with LAR-AP, we were able to narrow down the region required for staining to a small interval (57E1-9) just proximal to the Egfr gene. The interval contains only four identified genes: Sdc, Sara, Fkbp13, and MESK2 ( Figure 1J ).
Syndecan Is a Ligand for LAR
Sdc, a transmembrane HSPG, was the logical candidate for the LAR ligand encoded in this region, because it is the only predicted cell-surface protein. Furthermore, an avian LAR ortholog had already been shown to bind to HSPGs [6] . To test this hypothesis, we examined Sdc mutant embryos for LAR-AP staining. We used three different Sdc mutations. Sdc Df(2R)48 is a w20 kb deletion that removes N-terminal Sdc coding region and also deletes all or part of the Sara and Fkbp13 genes [20] . Sdc 10608 and Sdc KG06163 are independent P element insertion mutations in an Sdc intron ( Figure 1J ). All three of these mutations eliminated the dot-like LAR-AP staining of muscle attachment sites and glia ( Figures 1D and 1E , Table S1 ). Mutations in Sara or Fkbp13 had no effect on LAR-AP staining (Table S1) .
Sdc mRNA and protein are expressed in a variety of tissues in the embryo [14, 20, 21] . Strikingly, Sdc protein is expressed at high levels in a dot-like pattern at muscle attachment sites, and this pattern appears identical to that component of the peripheral LAR-AP staining pattern that is eliminated by Sdc mutations (compare Figures 1C and 1G) . Sdc is also expressed at high levels on CNS axons ( Figure 1F ), which stain with LAR-AP. However, staining of CNS axons by LAR-AP is retained in zygotic Sdc mutants ( Figure 1D ), although staining for Sdc is greatly reduced (Figures 1H and 1I) , indicating that other putative LAR ligand(s) are also localized to axons (see below). LAR-AP staining of muscle attachment sites can be blocked by adding excess heparin, a highly sulfated form of HS. This implies that LAR-AP interacts with Sdc through its HS-GAG side chains, rather than with the Sdc protein core. In keeping with this, LAR-AP binding to the periphery is eliminated in embryos mutant for sulfateless (sfl), sugarless (sgl), and tout-velu (ttv) (Figure S1 , Table S1 ). These genes encode enzymes that are necessary for GAG chain synthesis and sulfation, and HSPG levels are reduced in zygotic mutant larvae lacking each of these enzymes [23] .
The Drosophila genome encodes two other cell-surface HSPGs, the glypicans Dally and Dally-like (Dlp) [24, 25] . There is also a Perlecan, an extracellular matrix HSPG, encoded by the trol gene [26, 27] . To examine whether any of these proteins contribute to the LAR-AP staining pattern observed on wild-type embryos, we stained dally single mutants, dally dlp double mutants, and trol mutants. No changes from the normal staining pattern were observed ( Figure S1 , Table S1 ).
To further demonstrate that LAR-AP interacts with Sdc, we ectopically expressed Sdc in muscles and showed that this ectopic muscle Sdc can be recognized by LAR-AP. LAR-AP was also able to bind to the glypican Dally when it was expressed at high levels on muscles ( Figure S2 ).
Evidence for a Second LAR Ligand
In Sdc mutants, while the bright dot-like LAR-AP staining at muscle attachment sites is absent, staining of CNS axons is still prominent ( Figure 1D ). There are also faint double lines extending into the periphery in each (Table S1) .
To characterize interactions with the putative second, non-HSPG, LAR ligand(s), and to further prove that LAR-AP interacts with Sdc through its GAG chains, we expressed mutant versions of LAR-AP with point mutations in putative HS binding motifs in the first Ig domain. Such mutants would be expected to be unable to interact with Sdc but might bind normally to non-HSPG ligands.
We made two mutants that we predicted would eliminate HS binding based on sequence analysis and on the RPTPσ mutants made by [6] . The canonical HS binding motif is BBXBB (B = K or R) [ Figures 2G and 2H) , an identical pattern of staining is observed with the two fusion proteins. Similar results were obtained with LAR-HS1-AP (Table  S1 ). In summary, these findings indicate that at least one other cell-surface-associated protein can interact with the extracellular domain of LAR and that this interaction is not mediated through HS GAGs. This second LAR ligand (or ligands) is expressed on CNS axons and in a distinct pattern in the periphery.
LAR Interacts with Sdc and Heparin In Vitro
We characterized interactions of LAR and the other RPTPs with HS in vitro using a solid-phase binding assay with heparin-agarose beads. In this assay, beads were mixed with each AP fusion protein at the same fusion protein concentration (approximately 2 nM), so that the extent of binding reflects the relative affinity of each fusion protein for the beads. These results showed We were also able to coimmunoprecipitate LAR-AP and Sdc by mixing LAR-AP protein with supernatant from Sdc-FLAG-transfected HEK 293T cells, precipitating the secreted Sdc with anti-FLAG, and detecting LAR-AP by immunoblotting with anti-PLAP ( Figure S3 ). In summary, these results indicate that LAR binds selectively to HS and to Sdc in vitro.
Sdc Contributes to LAR's Motor Axon Guidance Function
Lar mutants display a characteristic motor axon guidance phenotype called ISNb bypass [8, 10] . ISNb axons normally innervate the VLM field, including muscles 6, 7, 12, and 13. These axons initially fasciculate with the common ISN pathway, exiting the CNS via the ISN root. They then leave the ISN at the exit junction and grow into the muscle field ( Figures 4A, 4B, and 4D) . In Lar mutant embryos, ISNb axons successfully split away from the ISN pathway at the exit junction, but then some or all of these axons fail to grow into the muscle field at their normal entry point. Instead, they travel along parallel to the ISN, underneath the muscles, until they reach the dorsal edge of the VLM field ( Figures 4C,  4E, and 4F) . Zygotic null Lar mutant embryos display a complete or partial ISNb bypass phenotype with a To determine whether Sdc's interactions with LAR are important for ISNb axon guidance, we studied genetic interactions between Lar and Sdc. We first examined embryos homozygous for each of the three Sdc alleles described above (zygotic Sdc mutants), as well as maternal/zygotic Sdc mutants, and we found that they display ISNb bypass at frequencies only slightly greater than in wild-type ( Figure 4I, Figure S4A ). We then combined the three Sdc mutations with three different Lar mutations and evaluated whether the penetrance of the ISNb bypass phenotype in these double mutants was increased above the levels observed in the corresponding Lar single mutants.
. Sdc Participates in LAR-Mediated ISNb Axon Guidance (A-C) Schematic diagrams of ISNb axons and their muscle targets at late stage 16. The ISNb is blue, ISN is red, ISNd is dark green, and the VLMs (numbered) are light green. Dorsal is at top. (A) Normal ISNb pathway, side view (internal to left). The ISNb leaves the ISN at the exit junction (EJ) and turns inward to target the VLMs. It is thus in a more superficial focal plane than the ISN when viewed from the internal side (as in a filet preparation). (B) Top view, like that seen in a filet preparation. The ISNb has begun to form synapses on the VLMs (horizontal bars). The ISNd extends
We initially made double mutants with each of the three Sdc mutations together with the hypomorphic allele Lar bypass , for which the bypass phenotype occurs at a penetrance of about 10%. This mutation introduces a frame shift that causes deletion of the second PTP domain [30] . These double mutants had bypass phenotypes indistinguishable from those in Lar mutants and did not display any new motor axon guidance phenotypes. For each of the Sdc alleles, the bypass penetrance in the double mutants is increased by more than 2-fold above that seen for Lar bypass . The largest effect is observed for Sdc 10608 , where penetrance increases from 10% in Lar bypass to 26% in Lar bypass Sdc 10608 (Figure 4I; p < 0.01) .
We also combined Sdc Df48 and Sdc 10608 with Lar
13.2
and Lar 5.5 , which are early stop codon (presumed null) mutations, and evaluated bypass phenotypes in the resultant double transheterozygote. These double mutants displayed an increased penetrance of the bypass phenotype (43%; Figures 4G-4I ) relative to the corresponding Lar transheterozygote (28%; p < 0.01). This indicates that removal of Sdc reduces the residual LAR function that is retained in zygotic Lar-null embryos.
We combined Sara and Fkbp13 mutations with Lar bypass in order to ensure that effects of Sdc mutations on these genes were not responsible for the increase in bypass frequency observed in Lar Sdc combinations. To determine if the interactions between Lar and Sdc were specific for this HSPG, or might be also observed for the other cell-surface HSPGs, we also examined double and triple mutants in which Lar bypass was combined with Dally and Dlp mutations. In all of these cases, no increase in the frequency of the bypass phenotype over that seen in the Lar single mutant was observed ( Figure S4A ). To do this, we first needed to define a gain-of-function (GOF) Lar axon guidance phenotype and then determine if this same phenotype can be produced by overexpressing Sdc on muscles. We could then perform an epistasis test, determining whether genetic removal of LAR function would be able to suppress the Sdc overexpression phenotype. If so, this would suggest that the axon guidance phenotype caused by Sdc overexpression arises through an increase in LAR's signaling activity mediated by interactions between muscle Sdc and neuronal LAR.
Sdc Expressed on Muscles Can Function as a Ligand for Neuronal LAR
We first examined motor axons in embryos in which wild-type LAR was overexpressed in neurons, and we found guidance phenotypes affecting the SNa nerve. No ISNb phenotypes were observed. SNa axons leave the CNS in the SN root, and the nerve bifurcates dorsal to muscle 12 and splits into two branches that innervate muscles 21-24 (anterior branch) and muscles 5 and 8 (posterior branch) (Figures 6A and 6B) . LAR overexpression from the elav-GAL4 driver produced SNa bifurcation phenotypes with a frequency of 23%. The anterior and posterior branches were equally likely to be affected (Figures 6C and 6F ). This is a specific Lar GOF phenotype; Lar LOF mutants do not display SNa phenotypes ( [11] and Figure S4A ). However, Ptp52F LOF mutants display this same SNa phenotype, with a similar penetrance (28% for nulls). Interestingly, LAR and PTP52F have opposing activities in regulation of CNS axon guidance [12] .
Generation of the Lar SNa GOF phenotype requires enzymatic activity, because overexpression of a LAR mutant with point mutations of the essential catalytic cysteine residues in both PTP domains does not produce SNa phenotypes at a greater frequency than the isogenic control ( Figure 6F) .
We then examined motor axon guidance in embryos overexpressing Sdc in muscles using the 24B-GAL4 driver and found identical SNa bifurcation phenotypes ( Figures 6D-6F) , with a penetrance of 18%; again, no ISNb phenotypes were observed. These results show that exposure of SNa motor axons to excess muscle Sdc causes bifurcation failures. We could now perform the key epistasis experiment, determining whether these phenotypes are suppressed when LAR is genetically removed from the motor axons. We introduced a Lar null mutant combination into lines in which Sdc is overexpressed in muscles. This completely suppressed the SNa bifurcation phenotype (to 7%, versus 6% for the isogenic UAS-Sdc insertion line control; Figure 6F ; p < 0.001). These results indicate that Sdc on muscles can function in vivo as a ligand for LAR on motor axons and suggests that interaction in trans with Sdc increases LAR's signaling activity. Finally, to examine the specificity of the Sdc GOF phenotype, we also tested muscle overexpression of the glypicans Dally and Dlp using the 24B and G14 drivers. Dally overexpression produced SNa bifurcation phenotypes at a low penetrance (12%), while Dlp overexpression did not produce any phenotype ( Figure S4B ).
Discussion
In this paper, we identify the HSPG Sdc as a ligand for the RPTP LAR, a neuronal transmembrane receptor that regulates axon guidance in embryos and larvae. LAR interacts with the GAG chains of Sdc and binds to heparin and Sdc with nanomolar affinity (Figure 3) . Genetic interaction studies using Sdc and Lar LOF mutations demonstrate that Sdc contributes to LAR's function in motor axon guidance (Figure 4) . We also show that overexpression of Sdc on muscles generates the same phenotype as overexpression of LAR in neurons and that genetic removal of LAR suppresses the phenotype produced by ectopic Sdc (Figure 6 ). These results demonstrate that Sdc can interact with LAR in trans and suggest that Sdc is a positive regulator of LAR signaling in growth cones.
Using Deficiency Screens to Identify Ligands for Cell-Surface Receptors
We describe a new strategy for identification of ligand genes. First, the extracellular domain of the cell-surface receptor of interest is expressed as an AP fusion protein [33] . Second, the AP fusion protein is used to stain live-dissected Drosophila embryos to reveal the expression pattern of the putative ligand. Third, embryos homozygous for each of the deletion mutations in the Bloomington deficiency kit (which currently covers >92% of the genome) are dissected and stained with the AP fusion protein. If a deletion is identified that eliminates all or part of the staining pattern, overlapping deficiencies and insertion mutations can then be screened to isolate the gene responsible for the staining.
This type of screen has several advantages over expression cloning from cDNA library pools in transfected mammalian cells. First, expression cloning requires fulllength cDNA clones and is thus difficult if the ligand mRNA is rare and/or large. This is not a concern with the deficiency screen, since one is searching for regions whose deletion eliminates staining, not for clones that confer staining. Second, if two or more subunits must come together to create a binding-competent ligand, this ligand will not be expressed by cells transfected with library pools, since any given pool would be unlikely to contain cDNAs for both subunits. However, the absence of a gene encoding one of the subunits would still be detected by the deficiency screen. Third, expression cloning is normally limited to cell-surface ligands, because soluble ligands would diffuse away from the transfected cell. The deficiency screen can permit cloning of genes encoding soluble ligands, as long as these remain attached to structures in the embryo during incubation with the AP fusion protein.
There are, however, several problems with the deficiency screen approach. First, about 1/4 of kit deficiencies cannot be screened because homozygous embryos have such severe phenotypes that staining patterns cannot be recognized. This is due to removal of genes (e.g., Egfr at 57E9; Table S1 ) whose zygotic expression is necessary for early development. To address this problem, we are examining smaller deletions in these "unscreenable regions" in order to narrow down the regions that cannot be screened to the smallest possible intervals around critical genes such as Egfr. Second, the deficiency screen does not necessarily locate the actual ligand genes; it would also identify regions encoding genes required for ligand synthesis. For example, deletion of the ttv, sgl, or sfl genes, which encode enzymes required for GAG synthesis, eliminates or reduces peripheral staining with LAR-AP, since these enzymes are necessary to make binding-competent Sdc. Finally, some receptors may recognize multiple ligands that are expressed in the same or similar patterns. In this case, a deletion removing the gene encoding one of these ligands might not perturb staining sufficiently to allow it to be identified in a screen. This is presumably the case for the second CNS ligand of LAR-AP (Figures 1 and 2) . Sdc is also expressed on CNS axons; thus, a deficiency removing the CNS ligand would probably not eliminate axonal LAR-AP staining since Sdc would still be present in these embryos. To deal with this problem, we are now rescreening the deficiency kit with LAR-HS2-AP (Figures 2 and 3) , a point mutant that cannot interact with Sdc.
Regulation of Motor Axon Guidance by Sdc
Genetic removal of Sdc from embryos bearing Lar mutations increases the penetrance of the characteristic Lar ISNb bypass phenotype. This effect on penetrance is as large as those usually observed when a second RPTP is genetically removed from a single Rptp mutant (e.g., removal of DPTP69D from a Lar mutant [10] ).
Removal of Sdc increases penetrance for both hypomorphic and (zygotic) null Lar mutations (Figure 4) . The effect on the null penetrance is likely due to reduction of maternally contributed LAR function [10] . However, we found that Sdc mutations alone do not produce ISNb bypass at a significant frequency, even when both maternal and zygotic Sdc are removed (Figure 4, Figure  S4A ). One explanation for this finding might be that Sdc is partially redundant with Dally and/or Dlp, since these are cell-surface HSPGs expressed in a similar pattern to Sdc.
To test this model, we reduced Dally and Dlp expression in an Sdc mutant background. It is difficult to assess the appropriate extent of reduction for this experiment. Glypicans cannot be completely removed, since this would produce embryos with severe early phenotypes due to loss of Hedgehog and Wingless signaling (reviewed by [15, 16] ). We generated zygotic triple mutants (Sdc dally dlp), and we also injected dally and dlp dsRNAs into Sdc maternal/zygotic mutant embryos (dally/dlp RNAi would affect both maternal and zygotically contributed mRNAs). The genetic triple mutants had CNS phenotypes that are stronger than the Sdc phenotype [20, 21] but displayed few motor axon guidance errors. Dally/Dlp-injected Sdc mutant embryos had more severe phenotypes, but ISNb guidance was not selectively affected (data not shown). Overall, our data suggest that Sdc is not redundant with Dally or Dlp and that its absence is likely to be compensated for by non-HSPG proteins. Perhaps the second LAR ligand that we detect by embryo staining is redundant with Sdc. Like Sdc, this ligand is expressed both on CNS axons and in lines in the periphery (Figure 2) .
The genetic epistasis experiment of Figure 6 demonstrates that Sdc acts in trans (as a ligand) to regulate LAR function. However, these data allow us to reach this conclusion only for SNa bifurcation, which is affected by LAR overexpression but not by loss of LAR. In its regulation of the decision of ISNb growth cones to enter the muscle field, Sdc could also act as a ligand, since it is expressed at the appropriate time on patches of cells near the muscle field entry site that could be contacted by LAR-expressing ISNb growth cones at this choice point ( Figure 5) . Alternatively, Sdc could act as a coreceptor at this choice point since it is expressed on the motor nerves together with LAR. Finally, we do not know if the Sdc that interacts with LAR during ISNb axon guidance is attached to the cell surface or has been shed by proteolytic cleavage. If released Sdc is the essential ligand, this could be expressed by either muscles or neurons and transported to the choice point.
Conclusions
Our results show that the cell-surface HSPG Sdc is an in vivo ligand for LAR and indicate that it positively regulates LAR signaling during motor axon guidance. Sdc's GAG chains bind directly to LAR with high affinity, and this binding requires basic sequences in the first Ig domain of LAR. Further work will be required to determine whether binding to Sdc directly stimulates
